Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma.

MLA

Ji, Xiang Lu, and Ming He. “Sodium Cantharidate Targets STAT3 and Abrogates EGFR Inhibitor Resistance in Osteosarcoma.” Aging, vol. 11, no. 15, Aug. 2019, pp. 5848–63. EBSCOhost, https://doi.org/10.18632/aging.102193.

APA

Ji, X. L., & He, M. (2019). Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma. Aging, 11(15), 5848–5863. https://doi.org/10.18632/aging.102193

Chicago

Ji, Xiang Lu, and Ming He. 2019. “Sodium Cantharidate Targets STAT3 and Abrogates EGFR Inhibitor Resistance in Osteosarcoma.” Aging 11 (15): 5848–63. doi:10.18632/aging.102193.